[go: up one dir, main page]

NO20014099D0 - Pyridazin-3-on derivater og medikamenter inneholdende disse - Google Patents

Pyridazin-3-on derivater og medikamenter inneholdende disse

Info

Publication number
NO20014099D0
NO20014099D0 NO20014099A NO20014099A NO20014099D0 NO 20014099 D0 NO20014099 D0 NO 20014099D0 NO 20014099 A NO20014099 A NO 20014099A NO 20014099 A NO20014099 A NO 20014099A NO 20014099 D0 NO20014099 D0 NO 20014099D0
Authority
NO
Norway
Prior art keywords
group
substituted
unsubstituted
pyridazin
medicines
Prior art date
Application number
NO20014099A
Other languages
English (en)
Other versions
NO319832B1 (no
NO20014099L (no
Inventor
Masao Ohkuchi
Yoshinori Kyotani
Hiromichi Shigyo
Hideo Yoshizaki
Tomoyuki Koshi
Takahiro Kitamura
Takayuki Matsuda
Kyoko Yasuoka
Tomoko Furuyama
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO20014099D0 publication Critical patent/NO20014099D0/no
Publication of NO20014099L publication Critical patent/NO20014099L/no
Publication of NO319832B1 publication Critical patent/NO319832B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
NO20014099A 1999-02-26 2001-08-23 Pyridazin-3-on-derivater og medikamenter inneholdende disse samt anvendelse av derivatene. NO319832B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11049758A JP2000247959A (ja) 1999-02-26 1999-02-26 ピリダジン−３−オン誘導体及びこれを含有する医薬
PCT/JP2000/001098 WO2000050408A1 (en) 1999-02-26 2000-02-25 Pyridazin-3-one derivatives and medicines containing the same

Publications (3)

Publication Number Publication Date
NO20014099D0 true NO20014099D0 (no) 2001-08-23
NO20014099L NO20014099L (no) 2001-10-23
NO319832B1 NO319832B1 (no) 2005-09-19

Family

ID=12840099

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014099A NO319832B1 (no) 1999-02-26 2001-08-23 Pyridazin-3-on-derivater og medikamenter inneholdende disse samt anvendelse av derivatene.

Country Status (18)

Country Link
US (1) US6680316B1 (no)
EP (1) EP1156039B1 (no)
JP (2) JP2000247959A (no)
KR (1) KR100647726B1 (no)
CN (1) CN1148355C (no)
AT (1) ATE305926T1 (no)
AU (1) AU764393B2 (no)
CA (1) CA2364801C (no)
DE (1) DE60022986T2 (no)
DK (1) DK1156039T3 (no)
ES (1) ES2250100T3 (no)
HK (1) HK1044534B (no)
HU (1) HUP0200088A3 (no)
NO (1) NO319832B1 (no)
NZ (1) NZ513578A (no)
RU (1) RU2232755C2 (no)
TW (1) TWI249533B (no)
WO (1) WO2000050408A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2209813C2 (ru) * 1997-11-19 2003-08-10 Кова Ко., Лтд. Производные пиридазина, лекарственные средства на их основе и способ лечения артрита
ATE425148T1 (de) * 2000-09-18 2009-03-15 Eisai R&D Man Co Ltd Triazinone sowie deren medizinale anwendung
AU761191B2 (en) * 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
CN1304379C (zh) * 2001-09-26 2007-03-14 兴和株式会社 水溶性苯基哒嗪衍生物及含有该衍生物的药物
NZ541064A (en) * 2003-03-07 2007-09-28 Kowa Co Benzofuran derivative
AU2004221966A1 (en) * 2003-03-18 2004-09-30 Kowa Co., Ltd. Water-soluble phenylpyridazine derivative and medicine containing the same
WO2004094379A2 (en) * 2003-04-16 2004-11-04 Amgen Inc. 3-phenyl-4- (pyrimidin-2-yl) -6- (piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations
ES2251866B1 (es) * 2004-06-18 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
WO2007044796A2 (en) * 2005-10-11 2007-04-19 Nps Pharmaceuticals, Inc. Pyridazinone compounds as calcilytics
US20090131443A1 (en) * 2005-10-28 2009-05-21 Kowa Co., Ltd. Method for prevention and/or treatment of rheumatoid arthritis
RS56331B1 (sr) * 2013-02-07 2017-12-29 Merck Patent Gmbh Derivati piridazinon-amida
CA2970550C (en) * 2015-02-06 2023-09-19 Merck Patent Gmbh Pyridazinone macrocycles as irak inhibitors and uses thereof
FR3103701B1 (fr) * 2019-11-28 2021-11-26 Inst Nat Sante Rech Med Composés de typen2-arylméthyl-4-haloalkyl-pyridazin-3-one et leur utilisation
CA3170324A1 (en) * 2020-02-14 2021-08-19 Fmc Corporation Substituted 5,6-diphenyl-3(2h)-pyridazinones for use as fungicides

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2839532A (en) * 1958-06-17 Pyridazone compounds and process of
GB788393A (en) * 1953-04-30 1958-01-02 Ciba Ltd Process for the manufacture of pyridazone compounds
US3840597A (en) 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
AR206496A1 (es) 1972-07-03 1976-07-30 Riker Laboratories Inc Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas
US4238490A (en) 1979-02-12 1980-12-09 Diamond Shamrock Corporation Antihypertensive pyridazin(2H)-3-ones
US4545810A (en) 1980-08-07 1985-10-08 Sds Biotech Corporation Herbicidal and plant growth regulant diphenylpyridazinones
WO1982000402A1 (en) * 1980-08-07 1982-02-18 Shamrock Corp Diamond Herbicidal and plant growth regulant diphenylpyridazinones
JPH0753725B2 (ja) 1987-10-08 1995-06-07 富山化学工業株式会社 ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
FI91062C (fi) 1988-12-28 1994-05-10 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisten naftaleenijohdannaisten valmistamiseksi
IL104369A0 (en) 1992-01-13 1993-05-13 Smithkline Beecham Corp Novel compounds and compositions
EP0628550B1 (en) * 1993-06-08 1998-02-25 Sanofi Pyridazines as interleukin-1beta converting enzyme inhibitors
AU699148B2 (en) 1995-08-10 1998-11-26 Merck & Co., Inc. 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
EP1007515A1 (en) 1997-08-22 2000-06-14 Abbott Laboratories Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
ATE319691T1 (de) 1997-08-22 2006-03-15 Abbott Lab Prostaglandin endoperoxyde h synthase biosynthese inhibitoren
RU2209813C2 (ru) * 1997-11-19 2003-08-10 Кова Ко., Лтд. Производные пиридазина, лекарственные средства на их основе и способ лечения артрита
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
CZ300570B6 (cs) 1998-10-27 2009-06-17 Abbott Laboratories Inhibitory biosyntézy prostaglandin endoperoxid H synthasy

Also Published As

Publication number Publication date
TWI249533B (en) 2006-02-21
EP1156039B1 (en) 2005-10-05
CA2364801C (en) 2009-05-19
NO319832B1 (no) 2005-09-19
KR20010101979A (ko) 2001-11-15
JP2000247959A (ja) 2000-09-12
DE60022986T2 (de) 2006-05-11
HK1044534B (zh) 2004-12-10
CA2364801A1 (en) 2000-08-31
AU764393B2 (en) 2003-08-14
EP1156039A4 (en) 2002-04-17
HK1044534A1 (en) 2002-10-25
CN1341103A (zh) 2002-03-20
KR100647726B1 (ko) 2006-11-23
HUP0200088A2 (hu) 2002-11-28
DK1156039T3 (da) 2006-01-30
AU2692800A (en) 2000-09-14
CN1148355C (zh) 2004-05-05
RU2232755C2 (ru) 2004-07-20
WO2000050408A1 (en) 2000-08-31
ATE305926T1 (de) 2005-10-15
US6680316B1 (en) 2004-01-20
EP1156039A1 (en) 2001-11-21
JP4456765B2 (ja) 2010-04-28
HUP0200088A3 (en) 2002-12-28
DE60022986D1 (de) 2006-02-16
ES2250100T3 (es) 2006-04-16
NZ513578A (en) 2005-04-29
NO20014099L (no) 2001-10-23

Similar Documents

Publication Publication Date Title
NO20014099L (no) Pyridazin-3-on-derivater og medikamenter inneholdende disse
KR987000261A (ko) 벤즈아미드옥심 유도체, 그의 제법 및 농원예용 살균제 (Benzamidoxime Derivative, Proecss for Production Thereof,and Agrohorticultural Bactericide)
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
BR9813848A (pt) Composto heterocìclico fundido substituìdo, uso do mesmo, e, composição farmacêutica.
EP1386923A4 (en) NEW ADENINE DERIVATIVES
ATE193828T1 (de) Hypoglykämische dihydrochalconderivate
DE60118225D1 (de) Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
ATE253546T1 (de) Chalcon-derivate und medikamente die diese enthalten
AU6947401A (en) Phenylpyridazine derivatives and drugs containing the same
EP1092435A4 (en) ANTIDIABETIC DRUGS
ATE150964T1 (de) Restenosehemmer nach perkutaner koronarer arterioplastie
CA2011087A1 (en) Use of trifluoromethylphenylazolylmethyloxiranes as crop protection agents
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
DE60117847D1 (de) Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate
EP1130015A4 (en) PYRIDAZINONE DERIVATIVES
AU2318600A (en) Chondrongenesis promotors and indolin-2-one derivatives
PT1265891E (pt) Novos derivados heterociclicos ou benzenicos do acido lipoico sua preparacao e sua aplicacao a titulo de medicamentos
BR0308935A (pt) Inibidor de fosfodiesterase iv contendo derivado de piridilacrilamida
KR970702848A (ko) 아릴피페리딘 및 아릴피페라진 유도체 및 이를 함유하는 약제(Arylpiperidine and arylpiperazine derivatives and drugs containing the same)
ATE121073T1 (de) Herbizide acrylonitrilderivate.
EP1319658A4 (en) IMIDAZOLE DERIVATIVES OR SALTS THEREOF
ATE318265T1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
ATE367377T1 (de) Bis(5-aryl-2-pyridyl)derivate
DE69018741D1 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees